Sveriges Riksbank
| Bid date, 2021-01-29 | |
| Bid Submission Date | 2021-01-29 |
| Bid times | 10.30-11.00 (CET/CEST) on the Bid date |
| Offered Amount | 50 billion SEK |
| Maximum Permitted Bid Volume | 12.5 billion SEK from an individual bidder |
| Settlement Date | 2021-02-02 |
| Minimum Permitted Bid Volume | 10 million SEK per bid |
| Final Repayment Date | 2025-02-03 |
| Maximum Allocation | 25 per cent of Offered Amount |
| Allocation Time | Not later than 11.30 (CET/CEST) on the Bid date |
| Repayment Date | 2022-02-02 |
| Option Repayment Date 1 | 2023-02-02 |
| Option Repayment Date 2 | 2024-02-02 |
| Interest rate | The Riksbank´s applicable repo rate |
| Additional interest rate | 0.10 per cent |
| Confirmation of bids to e-mail | eol@riksbank.se |
Stockholm, 2021-01-27
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
Sanofi Winthrop Industrie24.12.2025 07:00:00 CET | Press release
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
